PUGLIATTI, Maura
 Distribuzione geografica
Continente #
NA - Nord America 5.656
AS - Asia 3.659
SA - Sud America 2.275
EU - Europa 2.020
AF - Africa 133
Continente sconosciuto - Info sul continente non disponibili 32
OC - Oceania 10
Totale 13.785
Nazione #
US - Stati Uniti d'America 5.508
BR - Brasile 2.007
SG - Singapore 1.324
CN - Cina 1.142
UA - Ucraina 809
DE - Germania 344
VN - Vietnam 317
HK - Hong Kong 293
IT - Italia 212
FR - Francia 173
FI - Finlandia 159
AR - Argentina 98
IN - India 72
BD - Bangladesh 67
TR - Turchia 66
GB - Regno Unito 55
EC - Ecuador 53
RU - Federazione Russa 53
SE - Svezia 52
IQ - Iraq 50
MX - Messico 49
CA - Canada 48
UZ - Uzbekistan 42
KR - Corea 37
PK - Pakistan 32
ZA - Sudafrica 29
CZ - Repubblica Ceca 27
VE - Venezuela 27
KE - Kenya 26
MA - Marocco 25
PY - Paraguay 23
JP - Giappone 20
PL - Polonia 20
CO - Colombia 19
ES - Italia 19
BE - Belgio 18
CL - Cile 17
ID - Indonesia 17
NL - Olanda 17
JO - Giordania 16
AE - Emirati Arabi Uniti 15
PE - Perù 15
IL - Israele 14
IR - Iran 14
OM - Oman 13
TN - Tunisia 13
SA - Arabia Saudita 12
AZ - Azerbaigian 11
UY - Uruguay 11
EG - Egitto 10
KZ - Kazakistan 10
HN - Honduras 9
KG - Kirghizistan 9
NP - Nepal 9
AU - Australia 8
CR - Costa Rica 8
DZ - Algeria 8
LT - Lituania 8
PA - Panama 8
PH - Filippine 8
RS - Serbia 8
JM - Giamaica 7
PS - Palestinian Territory 7
RO - Romania 7
AT - Austria 6
LB - Libano 6
SN - Senegal 6
IE - Irlanda 5
QA - Qatar 5
AL - Albania 4
BG - Bulgaria 4
BH - Bahrain 4
BN - Brunei Darussalam 4
BO - Bolivia 4
DO - Repubblica Dominicana 4
EU - Europa 4
GT - Guatemala 4
KW - Kuwait 4
MY - Malesia 4
NG - Nigeria 4
SY - Repubblica araba siriana 4
CI - Costa d'Avorio 3
CY - Cipro 3
DK - Danimarca 3
ET - Etiopia 3
HU - Ungheria 3
KH - Cambogia 3
NI - Nicaragua 3
PT - Portogallo 3
SV - El Salvador 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BY - Bielorussia 2
CH - Svizzera 2
EE - Estonia 2
GA - Gabon 2
PR - Porto Rico 2
AW - Aruba 1
BS - Bahamas 1
CG - Congo 1
Totale 13.744
Città #
Dallas 1.777
Singapore 634
Jacksonville 515
San Jose 460
Chandler 441
Hong Kong 292
Princeton 268
Ashburn 243
Beijing 222
Nanjing 192
Council Bluffs 180
Dearborn 180
Columbus 136
São Paulo 131
Ho Chi Minh City 115
Lauterbourg 110
Wilmington 109
Shanghai 94
Nanchang 78
Hanoi 70
Ann Arbor 67
Rio de Janeiro 65
Belo Horizonte 56
Changsha 53
Santa Clara 53
Brasília 49
Hebei 46
New York 46
Tianjin 46
Shenyang 45
Los Angeles 42
Jiaxing 38
Tashkent 38
Porto Alegre 37
Seoul 37
Mountain View 36
Campinas 29
Helsinki 28
Curitiba 25
Brno 24
Munich 24
Sassari 24
Boardman 23
San Francisco 23
Nairobi 22
Dhaka 21
Frankfurt am Main 21
Guayaquil 20
Rome 20
Haiphong 19
Jinan 18
Orem 18
Tokyo 18
Baghdad 17
Brussels 17
Denver 17
Hangzhou 17
Kunming 17
Toronto 17
Woodbridge 17
Amman 16
Guarulhos 16
Quito 16
Salvador 16
Warsaw 16
Norwalk 15
Ribeirão das Neves 15
San Mateo 15
Caxias do Sul 14
Chicago 14
London 14
Brooklyn 13
Milan 13
Montreal 13
Ankara 12
Asunción 12
Atlanta 12
Biên Hòa 12
Da Nang 12
Joinville 12
Santo André 12
Sorocaba 12
São José do Rio Preto 12
Campo Grande 11
Chennai 11
Florence 11
Fortaleza 11
Goiânia 11
Guangzhou 11
Houston 11
Istanbul 11
Manaus 11
Recife 11
Santiago 11
São José dos Campos 11
Zhengzhou 11
Baku 10
Buffalo 10
Cuiabá 10
Johannesburg 10
Totale 7.994
Nome #
A possible prognostic role for MSRV in multiple sclerosis. 274
3rd Alghero International Conference on Multiple Sclerosis, Pathogenesis and Treatment 205
Negative interaction between smoking and infectious mononucleosis in the risk of MS. 175
A questionnaire for multinational case-control studies of environmental risk factors in multiple sclerosis (EnvIMS-Q) 174
A narrative review of genetic and environmental factors and risk for multiple sclerosis. The design of the Italian multicentric PEDIGREE study 164
Carbamazepine in delayed-onset cerebellar tremor 158
C9ORF72 in a Large Series of Italian and Sardinian Familial and Sporadic ALS Patients 157
Personality traits predict perceived health-related quality of life in persons with multiple sclerosis 156
Analysis of eye movements abnormalities in mitochondrial encephalomyopathy (MELAS-MERRF) 153
Alpha b-crystallin-reactive T-cell lines in Sardinian multiple sclerosis and healthy controls 150
Acceptability and cross-cultural feasibility of a self-administered questionnaire on past exposure to putative environmental risk factors for multiple sclerosis 150
Acceptability and cross-cultural feasibility of it self-administered questionnaire on past exposure to putative environmental risk factors for multiple sclerosis 141
Sun exposure and multiple sclerosis risk in Norway and Italy: The EnvIMS study 140
Novel SPAST deletion and reduced DPY30 expression in a Spastic Paraplegia type 4 kindred. 138
Amyotrophic lateral sclerosis in Sardinia, insular Italy, 1995-2009. 138
A Cluster of ALS Cases in Sardinia Due to a Founder Mutation of the TARDBP Gene 135
An international case-control study of risk factors for multiple sclerosis 135
A large proportion of ALS cases in Sardinia are due to a single founder mutation of the TARDBP gene. Arch Neurol 134
Vestibular and somatosensory afferents modulate masseter muscle activity. 134
Incidence trend of multiple sclerosis in two Italian populations 132
Prevalence of multiple sclerosis in central Sardinia, Italy. 131
A Multicentric Prospective Incidence Study of Guillain-Barre Syndrome in Italy. the ITANG Study 131
An age at exposure effect in the association between sun exposure and the risk of MS in Norway and Italy. The EnvIMS study 130
The vestibular system modulates masseter muscle activity 129
Season of infectious mononucleosis and risk of multiple sclerosis at different latitudes; the EnvIMS Study. 129
A patient carrying a homozygous p.A382T TARDBP missense mutation shows a syndrome including ALS, extrapyramidal symptoms, and FTD. 128
Age at onset in affected pairs from Italian multiple sclerosis multiplex families. 128
Infantile-onset ascending hereditary spastic paralysis: a case report and brief literature review. 127
Comparing multiple sclerosis frequency in two different Italian provinces: evidence for a true risk rise in Sardinia. 127
A need for national registries and international collaborative research in multiple sclerosis 127
A genome screen for multiple sclerosis in Sardinian multiplex families 126
An age at exposure effect in the association between sun exposure and the risk of MS in Norway and in Italy. The EnvIMS study. 125
An epidemiological study of multiple sclerosis in central Sardinia, Italy 123
Accuracy of death certificates for amyotrophic lateral sclerosis varies significantly from north to south of Italy: implications for mortality studies 122
Preterm birth and long-term risk of epilepsy 119
Risk of Guillain-Barré syndrome after 2010-2011 influenza vaccination. 117
Does Pre-eclampsia increase the risk for epilepsy in adolescence and early adulthood? 116
Multiple sclerosis occurrence in relatives of Sardinian multiple sclerosis patients 115
The high prevalence of hereditary spastic paraplegia in Sardinia, insular Italy 115
Which syringomyelia is truly associated with multiple sclerosis? 114
Serum uric acid and multiple sclerosis 113
Reduced duration of breastfeeding is associated with a higher risk of multiple sclerosis in both Italian and Norwegian adult males: the EnvIMS study. 113
A cluster of ALS cases in Sardinia due to a founder mutation of the TARDBP gene. 112
An ALS Patient with a Homozygous A382T Missense Mutation of the TARDBP Gene 111
International case-control study on risk factors for multiple sclerosis (MS): pilot testing the questionnaire 111
Genetic Epidemiology Of Multiple Sclerosis (MS) In Sardinia: Spatial Cluster Analysis. 111
Age at onset in multiple sclerosis. 110
The burden of multiple sclerosis variants in continental Italians and Sardinians 107
Vestibular and somatosensory inputs modulate masseter muscle activity 107
Extracellular Release Of Multiple Sclerosis-Associated Retrovirus (MSRV) in Vivo and in Vitro and Cytokine Production By Sardinian MS Patients and Healthy Humans. 106
An international case control study of risk factors for multiple sclerosis 105
Serum uric acid in multiple sclerosis: further evidences of reduced levels. 105
Prevalence of multiple sclerosis in Central Sardinia. 104
Assess, compare and enhance the status of Persons with Multiple Sclerosis (MS) in Europe: a European Register for MS 104
Incidence of childhood and adolescence epilepsy: a community-based prospective study in the province of Ferrara and in Copparo, Italy, 1996-2005. 101
Epilepsy in Sardinia, insular Italy: a population-based prevalence study. 101
Event-Related Potentials in RR Multiple Sclerosis Patients on Combined Azathioprine And Interferon Beta-1a 101
Level of education and multiple sclerosis risk after adjustment for known risk factors: The EnvIMS study. 100
Multiple sclerosis in Sardinia. 99
The increasing incidence and prevalence of MS in a Sardinian province 99
Body size and the risk of multiple sclerosis in Norway and Italy: The EnvIMS study 99
Detection of Chlamydia Pneumoniae in the CSF of Sardinian patients with multiple sclerosis in the presence or absence of oligoclonal bands 98
Cost of disorders of the brain in Italy 98
Epidemiology of multiple sclerosis 98
The relationship between body size and the risk of multiple sclerosis. The EnvIMS study 97
The influence of index multiple sclerosis (MS) age at onset on the probability of having affected relatives. 97
Environmental risk factors of multiple sclerosis. Etiological comparative study between two italian genetically distinct population. 97
Multiple Sclerosis in Sardinia, insular Italy: the highest burden worldwide? 96
Gestosis and long-term risk of epilepsy. 96
Variation of the myelin oligodendrocyte glycoprotein gene is not primarily associated with multiple sclerosis in the Sardinian population 95
The relationship between body size and the risk for multiple sclerosis. The EnvIMS study. 95
The EnvIMS Study: Design and Methodology of an International Case-Control Study of Environmental Risk Factors in Multiple Sclerosis. 95
HLA-DR4 haplotype influences the cytokine production in Sardinian MS patients 94
Masseter muscle activity during vestibular stimulation 92
Estimation of the cost of MS in Europe – Extrapolations from a multinational cost study 90
Pharmacology of delayed-onset cerebellar tremors 90
Patient expression of emotions and neurologist responses in first multiple sclerosis consultations 89
Multiple sclerosis progression and in vitro production of TNF-alphaand IFN-gamma: no correlation in Sardinian patients. 89
Genomewide scan of multiple sclerosis in Sardinian multiplex families. 89
Disease Surveillance in Low Income Countries: ICT Intervention for TB in Tanzania 88
Epidemiological studies of multiple sclerosis in a Sardinian population, insular Italy. Cluster studies and health status 87
Multiple sclerosis registries in Europe - results of a systematic survey. 87
Neuromuscular transmission impairment and multiple sclerosis. 87
Multiple sclerosis 86
Does low socioeconomic status in early life protect against multiple sclerosis? A multinational, case-control study 85
Pudendal nerve SEP in possible and probable multiple sclerosis. 85
Anticipation of multiple sclerosis (MS) onset in children of parent/child pairs from Italian MS multiplex families. 83
Role Preferences of People with Multiple Sclerosis: Image-Revised, Computerized Self-Administered Version of the Control Preference Scale. 83
Multiple sclerosis: Preventing progression and disability in MS-when to treat? 82
HLA-based cytokine production in Sardinians: implications for the pathogenesis of multiple sclerosis. 82
Parent-Of-Origin Effect of HLA Genes In Sardinian Multiple Sclerosis 82
Cost of Brain Disorders in Italy: a Review 81
Qualiy of life (QoL) in multiple sclerosis (MS) patients 81
HLA contribute to multiple sclerosis susceptibility in Sardinian affected sib pairs. 80
Anticipation of multiple sclerosis (MS) onset in children of parent/child pairs from Italian MS multiplex families 80
Novel SPAST deletion and reducedDPY30expression in a spastic paraplegia type 4 kindred 79
Developing a tool-kit for measurement of risk factors in prospective harmonization of paediatric MS case-control studies. 78
The new electronic, self-administered version of the Control Preference Scale. 78
The role of ethnicity and native-country income in multiple sclerosis: the Italian multicentre study (MS-MigIT) 77
The Treatment experience, burden, and unmet needs (TRIBUNE) study - measuring the socioeconomic consequences of Multiple Sclerosis. 77
Totale 11.264
Categoria #
all - tutte 59.980
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.980


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022430 0 0 1 6 1 0 12 38 45 11 53 263
2022/2023829 143 90 26 98 84 128 0 69 140 8 29 14
2023/2024314 38 9 4 9 60 6 0 7 2 4 53 122
2024/20253.764 35 19 244 54 135 114 220 776 1.365 551 166 85
2025/20265.094 169 1.424 684 810 354 236 696 143 238 195 116 29
2026/2027515 127 388 0 0 0 0 0 0 0 0 0 0
Totale 13.785